Dan Puckett - 20 May 2022 Form 4 Insider Report for Shockwave Medical, Inc.

Role
Chief Financial Officer
Signature
s/ Wade Estey, as attorney-in-fact for Dan Puckett
Issuer symbol
N/A
Transactions as of
20 May 2022
Net transactions value
-$198,027
Form type
4
Filing time
27 May 2022, 16:40:57 UTC
Previous filing
20 Apr 2022
Next filing
22 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $966 +240 +0.6% $4.03* 40,178 20 May 2022 Direct F1
transaction SWAV Common Stock Options Exercise $18,870 +1,110 +2.8% $17.00* 41,288 20 May 2022 Direct F1
transaction SWAV Common Stock Sale $217,863 -1,350 -3.2% $161.38 41,048 20 May 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -240 -31% $0.000000 535 20 May 2022 Common Stock 240 $4.03 Direct F1, F3
transaction SWAV Stock Option Options Exercise $0 -1,110 -9.1% $0.000000 11,100 20 May 2022 Common Stock 1,110 $17.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022.
F2 All reported securities were sold at a price of $161.38.
F3 1/48th of the shares subject to the option shall vest monthly from 07/19/2018.
F4 1/48th of the shares subject to the option shall vest monthly from 03/06/2019.